Ozenoxacin Impurity 31 CAS CATO-C4X-279631
| CAS No. | CATO-C4X-279631 |
| Molecular Formula | C14H13Cl2NO3 |
| Molecular Weight | 314.16 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Based on its molecular formula C14H13Cl2NO3, Ozenoxacin Impurity 31 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 314.16 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
CATO supplies Ozenoxacin Impurity 31 (CAS CATO-C4X-279631), a pharmacopoeial impurity reference standard (molecular formula C14H13Cl2NO3, MW 314.16 g/mol) used for the identification and quantification of trace impurities in APIs.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Ozenoxacin Impurity 31 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C14H13Cl2NO3 |
| Molecular Weight | 314.16 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Ozenoxacin Standards
- Ozenoxacin Impurity 65 (CAS CATO-C4X-279665)
- Ozenoxacin Impurity 33 (CAS CATO-C4X-279633)
- Ozenoxacin Impurity 4 (CAS CATO-C4X-27964)
- Ozenoxacin Impurity 2 (CAS CATO-C4X-27962)
- Ozenoxacin Impurity 44 (CAS CATO-C4X-279644)
- Ozenoxacin Impurity 28 (CAS CATO-C4X-279628)
- Ozenoxacin Impurity 71 (CAS CATO-C4X-279671)
- Ozenoxacin Impurity 25 (CAS CATO-C4X-279625)
Recommended Standards
- tert-Butyl 3-(3-iodopropoxy)propanoate (CAS 2301916-64-1)
- N-(tert-Butyl)-6,8-dichloro-2-oxo-2H-chromene-3-carboxamide (CAS 701940-72-9)
- n-(2-Bromo-4-fluorophenyl)-2-(thiophen-3-yl)acetamide (CAS 1038737-49-3)
- Methyl 3-(2,6-dichlorophenyl)-5-isopropylisoxazole-4-carboxylate (CAS 278597-28-7)
- Palbociclib Impurity 201 (CAS CATO-C4X-1125201)
- Vaborbactam Impurity 10 (CAS CATO-C4X-347710)
- Fluvoxamine Impurity 12 (CAS CATO-C4X-195112)
- 1-(3-Methoxy-4-methylphenyl)-N-methylmethanamine (CAS 1094755-12-0)
- [2-Methanesulfonyl-1-(2-phenylethyl)-1h-imidazol-5-yl]methanol (CAS 1221341-55-4)
- tert-Butyl 3-[(2,6-difluorobenzyl)oxy]-1-azetidinecarboxylate (CAS 1121593-07-4)
- 2,4-Dimethoxy-6-phenoxypyrimidine (CAS 246538-87-4)
- 2,4-Dichloro-7-methylquinoline (CAS 102878-19-3)
- 4-Bromo-3-(trifluoromethoxy)pyridine (CAS 1361781-49-8)
- Neuropeptide GE (CAS 134748-04-2)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com